Clinical Trials on Subependymal+Giant+Cell+Astrocytoma

Total 1982 results

Medanta Institute of Clinical Research

Unknown

A Comparison of FDG-PET Versus MRI Based Target Volume Delineation in Glioblastoma and the Role of FDG-PET/CT in the Alteration of MRI Based Target Volumes.

Glioblastoma
Institut Claudius Regaud
NovoCure Ltd.

Not yet recruiting

Study of Biologic Tumor and Plasma Biomarkers of Response to TTFields in Patients Treated for Newly Diagnosed Glioblastoma (EXOFIELDS)

Glioblastoma

France
Erasmus Medical Center

Recruiting

Hitting the Mark: Introducing State-of-the-art MRI for Precision Radiotherapy of Glioblastoma (MOSAIC)

Glioblastoma

Netherlands
Charlotte Lemech
The University of New South Wales

Not yet recruiting

Immunotherapy Targeting of Cytomegalovirus Antigens in Glioblastoma

Glioblastoma
Rznomics, Inc.

Not yet recruiting

A Study to Evaluate the Safety, Tolerability and Efficacy of RZ-001 With Valganciclovir (VGCV) in Subjects With Glioblastoma

Glioblastoma
Ludwig-Maximilians - University of Munich

Recruiting

Protective VEGF Inhibition for Isotoxic Dose Escalation in Glioblastoma (PRIDE)

Glioblastoma

Germany
Kepler University Hospital

Recruiting

Immuno-Positron Emission Tomography (PET)-Glioma Study, a Proof-of-principle Imaging Study

Glioblastoma

Austria
Power Life Sciences Inc.

Not yet recruiting

Pinpointing the Factors Affecting Clinical Trial Experiences of Glioblastoma Patients

Glioblastoma
Peter Siesjö
Lund University

Recruiting

Antisecretory Factor Glioblastoma Phase 2 (AFGB2)

Glioblastoma

Sweden
Radboud University Medical Center
ZonMw: The Netherlands Organisation for Health Research and Development

Not yet recruiting

Glioblastoma Imaging Using a Strong Iron-like Bloodpool Contrast Medium?

Glioblastoma
Institut de cancérologie Strasbourg Europe
Centre Georges Francois Leclerc

Not yet recruiting

Contribution From PET-DOPA in Glioblastoma Re-irradiation - A Randomized Phase II Study (ReciDOPA)

Glioblastoma

France
Cantex Pharmaceuticals

Recruiting

Azeliragon and Chemoradiotherapy in Newly Diagnosed Glioblastoma

Glioblastoma

Spain
Istituto Clinico Humanitas

Recruiting

Glioblastoma Evaluation for Heterogeneity In RadioseNsitivity (GEHIRN)

Glioblastoma

Italy
Henan Provincial People's Hospital

Not yet recruiting

Radiogenomics in Glioblastoma: Correlation Between Multiparametric Imaging Biomarkers and Genetic Biomarkers

Glioblastoma

China
Seoul National University Boramae Hospital

Not yet recruiting

Conventional Versus Hypofractionated Radiotherapy With Temozolomide in Elderly Glioblastoma

Glioblastoma
Clinical Laserthermia Systems AB

Recruiting

Safety and Feasibility of MR-guided Laser Thermal Ablation of Brain Lesions

Glioblastoma

Sweden
Sun Yat-sen University

Recruiting

Newly Diagnosed Glioblastoma

Glioblastoma

China
The Affiliated Nanjing Drum Tower Hospital of Nanjing...

Recruiting

Neoadjuvant Temozolomide Combined With Simultaneous IMRT for Treatment of Glioblastoma

Glioblastoma

China
Fondazione I.R.C.C.S. Istituto Neurologico Carlo...

Recruiting

Immunotherapy With Autologous Tumor Lysate-Loaded Dendritic Cells In Patients With Newly Diagnosed Glioblastoma Multiforme (DENDR1)

Glioblastoma

Italy
NovoCure Ltd.

Recruiting

TIGER PRO-Active - Daily Activity, Sleep and Neurocognitive Functioning Study

Glioblastoma

Germany
Duke University

Recruiting

Longitudinal Assessment of Marrow and Blood in Patients With Glioblastoma (LAMB-G)

Glioblastoma

United States
Philogen S.p.A.

Recruiting

Safety and Efficacy of L19TNF Plus Temozolomide Chemoradiotherapy in Patients With Newly Diagnosed Glioblastoma (GLIOSUN)

Glioblastoma

Switzerland
University Hospital, Lille
Institut National de la Santé Et de la Recherche Médicale, France; Hemerion...

Recruiting

Dose Finding for Intraoperative Photodynamic Therapy of Glioblastoma (DOSINDYGO)

Glioblastoma

France, Belgium
People's Hospital of Guangxi
Liuzhou Workers Hospital; Cancer Hospital of Guangxi Medical University; First... and other collaborators

Not yet recruiting

Addition of Anlotinib Hydrochloride to the Stupp Regimen Versus the Stupp Regimen Alone for Newly Diagnosed Glioblastoma

Glioblastoma

China
University of Texas Southwestern Medical Center

Recruiting

Non-Contrast Perfusion Using Arterial Spin Labeled MR Imaging for Assessment of Therapy Response in Glioblastoma

Glioblastoma

United States
photonamic GmbH & Co. KG

Recruiting

PD L 506 for Stereotactic Interstitial Photodynamic Therapy of Newly Diagnosed Supratentorial IDH Wild-type Glioblastoma

Glioblastoma

Germany
Grupo Español de Investigación en Neurooncología
Tilray; Medical Cannabis Bike Tour; Voices Against Brain Cancer

Recruiting

TN-TC11G (THC+CBD) Combination With Temozolomide and Radiotherapy in Patients With Newly-diagnosed Glioblastoma (GEINOCANN)

Glioblastoma

Spain
Dana-Farber Cancer Institute
Merck Sharp & Dohme LLC; National Institutes of Health (NIH); Accelerate Brain... and other collaborators

Recruiting

Personalized NeoAntigen Cancer Vaccine w RT Plus Pembrolizumab for Patients With Newly Diagnosed GBM

Glioblastoma

United States
St. Joseph's Hospital and Medical Center, Phoenix

Terminated

Tumor Resection and Gliadel® Wafers, Followed by Temodar® With Standard Radiation or GammaKnife® for New GBM

Glioblastoma

United States
Sidney Kimmel Cancer Center at Thomas Jefferson...
NovoCure Ltd.

Completed

Temozolomide, Radiation Therapy, and Tumor Treating Fields Therapy in Treating Participants With Glioblastoma

Glioblastoma

United States
Grupo Español de Investigación en Neurooncología

Completed

Glasdegib (PF-04449913) With Temozolomide Newly Diagnosed Glioblastoma (GEINOGLAS)

Glioblastoma

Spain
Immunomic Therapeutics, Inc.

Active, not recruiting

Study to Evaluate the Safety, Tolerability, Immunogenicity and Preliminary Efficacy of ITI-1001 In Patients With Newly Diagnosed Glioblastoma (GBM)

Glioblastoma

United States
Washington University School of Medicine
The Foundation for Barnes-Jewish Hospital; Geneos Therapeutics

Active, not recruiting

Neoantigen-based Personalized DNA Vaccine in Patients With Newly Diagnosed, Unmethylated Glioblastoma

Glioblastoma

United States
InSightec

Completed

Assessment of Safety and Feasibility of ExAblate Blood-Brain Barrier (BBB) Disruption

Glioma | Glioblastoma

United States
Memorial Sloan Kettering Cancer Center

Withdrawn

Genetic Testing of Cerebrospinal Fluid to Diagnose and Monitor Glioblastoma

Glioblastoma

United States
University of Oklahoma

Active, not recruiting

OKN-007 in Combination With Adjuvant Temozolomide Chemoradiotherapy for Newly Diagnosed Glioblastoma

Glioblastoma

United States
InSightec

Completed

Assessment of Safety and Feasibility of ExAblate Blood-Brain Barrier (BBB) Disruption for Treatment of Glioma

Glioblastoma

Canada
Centre Hospitalier Universitaire de Besancon

Active, not recruiting

Anticancer Therapeutic Vaccination Using Telomerase-derived Universal Cancer Peptides in Glioblastoma (UCPVax-Glio)

Glioblastoma

France
Beijing Pearl Biotechnology Limited Liability Company

Active, not recruiting

A Study of PLB1001 Enteric Capsules in the Treatment of sGBM/IDH Mutant Glioblastoma Patients With the ZM Fusion Gene (FUGEN).

Glioblastoma

China
Maastricht Radiation Oncology

Active, not recruiting

Patient-derived Glioma Stem Cell Organoids

Glioblastoma

Netherlands
Beijing Sanbo Brain Hospital

Completed

A Trial of One-week on/One-week Off Temozolomide Versus Continuous Dose-Intense Temozolomide in Patients With Glioblastoma Multiforme at First Relapse

Glioblastoma
Northwestern University
National Cancer Institute (NCI)

Active, not recruiting

Nivolumab, BMS-986205, and Radiation Therapy With or Without Temozolomide in Treating Patients With Newly Diagnosed Glioblastoma

Glioblastoma

United States
Kiarash Shahlaie, M.D., Ph.D.
National Cancer Institute (NCI)

Completed

Systemic and Local Levels of Lidocaine During Surgery for the Removal of Glioblastoma

Glioblastoma

United States
Roswell Park Cancer Institute

No longer available

SurVaxM Expanded Access Protocol (EAP)

Glioblastoma
University of Aarhus

Withdrawn

TMS Electrochemotherapy for Glioblastoma Multiforme

Glioblastoma
University Hospital, Basel, Switzerland

Completed

Doxorubicin-loaded Anti-EGFR-immunoliposomes (C225-ILs-dox) in High-grade Gliomas (GBM-LIPO)

Glioblastoma

Switzerland
CytoVac A/S

Completed

Autologuos Lymphoid Effector Cells Specific Against Tumour (ALECSAT) as Add on to Standard of Care in Patients With Glioblastoma (ALECSAT)

Glioblastoma

Sweden
Memorial Sloan Kettering Cancer Center
Weill Medical College of Cornell University

Completed

89Zr-J591 Anti-Prostate-Specific Membrane Antigen Monoclonal Antibody in Patients With Glioblastoma Multiforme

Glioblastoma

United States
Tel-Aviv Sourasky Medical Center

Unknown

NovoTTF-200A Together With Radiation Therapy and Temozolomide in Patients With Newly Diagnosed GBM (NovoTTF-200A)

Glioblastoma

Israel
Boehringer Ingelheim

Completed

Open Label Trial to Explore Safety of Combining Afatinib (BIBW 2992) and Radiotherapy With or Without Temozolomide in Newly Diagnosed Glioblastoma Multiform

Glioblastoma

United Kingdom

3

Subscribe